Rajalakshmi Shanmugam

Rajalakshmi Shanmugam
Siddha Central Research Institute | SCRI · SCRU Tirupati

Doctor of Medicine

About

16
Publications
3,667
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
8
Citations
Introduction
Rajalakshmi Shanmugam currently works at the Siddha Clinical Research Unit (SCRU) Tirupati, Central Council for Research in Siddha. Their current project is integrative medicine.

Publications

Publications (16)
Article
Full-text available
COVID-19 is a deadly disease; at the time of the first COVID-19 wave (January 2020 to November 2020), so many deaths were reported worldwide. There were no standard conventional treatments and vaccines, so the whole world turned to traditional medicine. Siddha system of medicine is one of the traditional medicines practiced in the southern part of...
Article
Full-text available
Integrative Medicine (IM) is a rapidly growing field because of increased demand, which requires further evidence-based research to provide more information on the effectiveness and safety. The aim of the study was to assess morbidity and drug utilization among patients using IM attending Siddha Clinical Research Unit (SCRU), Tirupati, India.The in...
Article
Full-text available
Siddha Clinical Research Unit (SCRU) Tirupati, working under the Central Council for Research in Siddha (CCRS), Ministry of AYUSH, Govt. of India, conducted a National Web conference titled “Integrated Siddha Approach in Clinical Practice and Research on COVID-19 Pandemic (ISACC)” on 23<sup>rd</sup> Dec 2020, as a part of the fourth Pre-Siddha Day...
Conference Paper
Full-text available
Article
Full-text available
COVID-19 (Corona Virus Disease-2019) is an infectious respiratory disease caused by the most recently discovered corona virus, SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona virus-2). This new viral disease was unknown before the outbreak began in Wuhan, China, in December 2019. As of November 16th 2020, it affects about 54.3 million populati...
Article
Full-text available
In India, according to WHO 2018 statistics, there were 63% of death occurred due to Non-communicable diseases (NCDs), in which Cardiovascular diseases were leading cause of death 27%, followed by Cancer 9%, Chronic respiratory disease 11%, Diabetes 3% and other NCDs 13%. This indicates that NCDs needs to become a priority in controlling and prevent...
Article
Full-text available
In India, according to WHO 2018 statistics, there were 63% of death occurred due to Non-communicable diseases (NCDs), in which Cardiovascular diseases were leading cause of death 27%, followed by Cancer 9%, Chronic respiratory disease 11%, Diabetes 3% and other NCDs 13%. This indicates that NCDs needs to become a priority in controlling and prevent...
Article
Full-text available
Background: In worldwide, 20-25% of the population have the Metabolic Syndrome (MetS). The highest prevalence rate reported in South Asia of MetS in the Punjabi community in India by Adult Treatment Panel III criteria. The metabolic syndrome (MetS) is a major and escalating public-health and clinical challenge worldwide in the wake of rapid urbaniz...
Article
Full-text available
Integrative medicine is an approach to integrated health care that focuses mainly on the patient with the range of physical, mental, emotional, social, and spiritual health of the person, which can help people with cancer, persistent pain, chronic fatigue, fibromyalgia, and many other conditions better manage their symptoms and improve their qualit...
Article
Full-text available
ABSTRACT Aim: The patients with psoriasis, like those with other major medical disorders, have reduced levels of employment and income as well as a decreased quality of life. The treatments such as methotrexate, cyclosporine have been used for many years, but the safety profile of this treatment is minimal. Hence an idea is created to conduct a cli...
Article
Full-text available
Background: Panchamuga chendhuram (PMC) is a Siddha Herbo-mineral formulation indicated for all skin diseases in classical Siddha literature Pullipani vaidhyam-500. It contains 5 ingredients Rasam (Mercury) (Hg), Gandhagam (Sulphur) (s), Lingam (Mercuric II sulfide) (Hgs), Thaalagam (Arsenic trisulphidium) (AS 2 S 3), Veeram (Mercuric chloride) (Hg...
Article
Full-text available
Objectives: This study was aimed at scientifically evaluating the in vitro antipsoriatic activity of Siddha drug Panchamuga Chendhuram (PMC) in human keratinocyte (HacaT) cell lines. Methods: The Siddha drug PMC tested for antipsoriatic activity on HacaT cell lines was morphologically examined by phase contrast microscopy, and the cell viability w...
Article
Full-text available
Background: Cancer remains to be the highest cause of mortality in the world and claims millions of human lives every year. Many systems are paying attention on cancer research to invent new interventions. It is evident that there are many anti canc erous drugs available in Siddha System of medicine. This study claims Veera Rasa Padhangam (VRP), Pa...

Network

Cited By

Projects

Projects (3)
Project
Integrative approch of Siddha system of medicine to metabolic syndrome